MyCEI Login


Best of ACTHIV® 2023: Approaches to ART Optimization in the Virally Suppressed Patient


Published Date: 09/15/2023

Expiration Date: 09/15/2024

CE Credit: CME:0.5


Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this module will provide guidance on when to consider an ART change in a virally suppressed person, and the use of 2-drug regimens.


Gretchen Snoeyenbos-Newman,MD

Gretchen Snoeyenbos Newman, MD, is an Assistant Professor of Infectious Disease at Wayne State University where she is the Director of Adult HIV Program and the Medical Director of Tolan Park Clinic, the largest HIV Clinic in Michigan. Her academic and clinical interests include care for women with HIV, novel models for care delivery, and medical education. Outside of work, she and her wife are proud mommies to their 2-year-old son.

Learning Objectives

  • Assess when to consider ART change in a virally suppressed person
  • Appraise when a 2-drug regimen is appropriate, and when it may be contraindicated

Continuing Education Credit Information